Tartu Biotechnology Park helps two more Health companies in the context of the Health Access program to start sales in Uganda and in South-Korea. Uganda Time is ripe for new partnerships and business relations in the Ugandan health sector. The business environment is relatively supportive, and the economic and political situation is stable enough to […]
There is a great Health Access programme that is willing to help you to start sales in one of these distant markets: India, Uganda, South-Korea or US. You will get: Needed information from the target market about regulations, business model opportunities, technological setup, competition, possible cooperation partners Adaptions needed for your company’s product and offering […]
Come and join the #BalticBlueBioAlliance – our experts will help you take your blue biotechnology idea to the next level! The Baltic Sea Region’s leading marine and biotechnology institutes have joined together and are opening their doors to you: labs, brains, resources, expertise and facilities are at your disposal. We offer assistance in all kinds […]
Health companies from Estonia, Latvia, Finland and Sweden have a unique opportunity to apply for a program to enter Indian or Uganda markets and achieve sales. The program is financed by Central Baltic Interreg and therefore the fee for companies is only 15% of the total cost. The program is delivered by health clusters from […]
The Kick-Off Meeting of the Baltic Fracture Competence Centre (BFCC) took place on the 21st and 22nd of April in Hamburg. The BFCC is a Baltic Sea region-wide collaborative project which got awarded with €3.6 M from the Interreg Baltic Sea Region Programme last December. It will foster an international approach to face the challenges […]
South Korea and USA – May 2016-Febr 2018 to achieve sales and find long term partners and clients in these target markets Market entry program includes: Needed information from the target market for your company: regulations, business model opportunities, technological setup, competition, possible cooperation partners Advice about adaptions needed for the company’s product and offering […]
Marine biotechnology has a significant potential to contribute to the well-being of the society as well as to the economic growth and sustainable development. The tremendous potential of blue biotechnology in Baltic Sea Region (BSR) is however underused and needs more strategic approaches for a full chain sector development. The recently funded Interreg BSR project […]
With the help of the Central Baltic Interreg programme, Tartu Biotechnology Park and Tallinn Science Park Tehnopol have launched CB Health Access project for the advancement of health tech entrepreneurship. The project will help to introduce Estonian, Finnish, Swedish and Latvian health tech companies, including e-health, medical technology and biotechnology companies, to new markets further […]
BFCC aiming for Innovation within fracture management and a transnational fracture registry platform composed of 6 hospitals from Denmark, Estonia, Germany, Lithuania, Poland and Sweden. In ageing societies, the need for innovative products and clinical procedures for fracture treatment is increasing due to more age-related fractures and comorbidities such as osteoporosis or post-surgery complications like […]
sTARTUp 2015 BioTech will take place on 30th October 2015 in Tartu, Garage48 HUB (Raekoja plats 16). The goal of sTARTUp Biotech is bringing together starting and established entrepreneurs in biotechnology, medicine and veterinary medicine. The event focuses on business development and execution of the ideas. We expect mainly students, researchers and novice entrepreneurs in […]
AS Ekspress Grupp has decided to launch a programme for investing in startup companies. The total fund of the first stage of the programme is 500,000 euros, which are intended for investing in the companies at an early stage in the Baltic States. In order to qualify for participation in the programme, a potential investee […]
9th Swiss-Scandinavian Bio-Business Seminar February 5, 2015 at SIX Stock Exchange building in Zurich. The 9th Swiss-Scandinavian Bio-Business Seminar is organized by the Nordic countries in cooperation with Swiss partners. During this high-level partnering and investor conference, Swiss and Nordic biotech and pharmaceutical companies as well as investors meet in one-to-one meetings and present themselves in plenum. […]
SMi present their 7th Annual Social Media in the Pharmaceutical Industry conference. Markets have become conversations. Social media is the online platform and location that provides a way for people to participate in these conversations. It’s a way to tap into what people are saying about a brand, a product or a service: participate in […]
On Wednesday 3 December, Biocat will hold an event including the regional closing session for the European ETTBio Effective Technology Transfer in Biotechnology project and the BioEmprenedorXXI awards ceremony. The event will have two parts. The first will feature three workshops organized to accompany the final ETTBio report, dealing with several topics associated with entrepreneurship […]
